<DOC>
	<DOC>NCT01026103</DOC>
	<brief_summary>The objectives of this clinical trial are to assess in a pilot setting the overall performance and safety of the Endo GIA™ Stapler with Endo GIA™ SULU with Tri-Staple™ Technology when used in a gastric bypass procedure.</brief_summary>
	<brief_title>Tri Staple Technology Stapler Used in Gastric Bypass</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>The patient must be 1865 years of age. The patient has a BMI of 4060 kg/m2, or 3540 kg/m2 with one or more of following comorbidities: sleep apnea, hypertension, hyperlipidemia, coronary artery disease, gastro esophageal reflux disease, osteoarthritis, and diabetes and eligible for gastric bypass. The patient must be willing and able to participate in the study procedures and able to understand and sign the informed consent. The procedure is needed as revision bariatric surgery or the patient has had prior gastric surgery (nissen fundoplication, hiatal hernia, etc) The patient is pregnant. The patient has an active or history of, infection at the operative site. The patient is unable or unwilling to comply with the study requirements, followup schedule, or to give valid informed consent. Patient has an abdominal ventral hernia requiring mesh repair The patient has a history of clinically significant liver disease The patient has a history of drug or alcohol abuse within 2 years of enrollment The patient has a history of venous thrombosis or pulmonary embolism The patient has a history of coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>gastric bypass</keyword>
	<keyword>Gastric bypass surgery</keyword>
</DOC>